Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Blast Overpressure Waves Induce Transient Anxiety and Regional Changes in Cerebral Glucose Metabolism and Delayed Hyperarousal in Rats.

Awwad HO, Gonzalez LP, Tompkins P, Lerner M, Brackett DJ, Awasthi V, Standifer KM.

Front Neurol. 2015 Jun 17;6:132. doi: 10.3389/fneur.2015.00132. eCollection 2015.

2.

Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.

Zhang Y, Simpson-Durand CD, Standifer KM.

Br J Pharmacol. 2015 Jan;172(2):571-82. doi: 10.1111/bph.12701. Epub 2014 Jul 1.

PMID:
24666365
3.

Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Donica CL, Awwad HO, Thakker DR, Standifer KM.

Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb 8. Review.

4.

Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD.

Zhang Y, Gandhi PR, Standifer KM.

Mol Pain. 2012 Oct 20;8:76. doi: 10.1186/1744-8069-8-76.

5.

Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment.

Zhang Y, Donica CL, Standifer KM.

Neuropharmacology. 2012 Sep;63(3):427-33. doi: 10.1016/j.neuropharm.2012.04.028. Epub 2012 May 2.

PMID:
22575074
6.

Orphanin FQ/nociceptin activates nuclear factor kappa B.

Donica CL, Ramirez VI, Awwad HO, Zaveri NT, Toll L, Standifer KM.

J Neuroimmune Pharmacol. 2011 Dec;6(4):617-25. doi: 10.1007/s11481-011-9279-2. Epub 2011 May 6.

7.

Methylnaltrexone in the treatment of opioid-induced constipation.

Greenwood-Van Meerveld B, Standifer KM.

Clin Exp Gastroenterol. 2008;1:49-58. Epub 2008 Dec 14.

8.

The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment.

Bawa-Khalfe T, Altememi GF, Mandyam CD, Schwarz LA, Eikenburg DC, Standifer KM.

BMC Pharmacol. 2007 Dec 20;7:16.

9.
11.

Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor.

Desai AN, Salim S, Standifer KM, Eikenburg DC.

J Pharmacol Exp Ther. 2006 Jun;317(3):1027-35. Epub 2006 Mar 13.

12.

Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.

Ozsoy HZ, Thakker DR, Standifer KM.

Mol Pharmacol. 2005 Aug;68(2):447-56. Epub 2005 May 12.

13.
14.

Simultaneous alpha2B- and beta2-adrenoceptor activation sensitizes the alpha2B-adrenoceptor for agonist-induced down-regulation.

Desai AN, Standifer KM, Eikenburg DC.

J Pharmacol Exp Ther. 2004 Nov;311(2):794-802. Epub 2004 Jun 10.

15.
16.

Assessing opioid regulation of adenylyl cyclase activity in intact cells.

Thakker DR, Ozsoy HZ, Standifer KM.

Methods Mol Med. 2003;84:29-37. No abstract available.

PMID:
12703314
17.
19.

Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.

Thakker DR, Standifer KM.

Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):38-46.

PMID:
12399106
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk